Top news of the week: 16.03.2022.
Companies And Industries
Three Biopharma Companies to Settle into New Breakthrough Properties Home
On Wednesday, Breakthrough Properties announced the launch of StudioLabs, a turnkey, flexible lab and office solution that has been developed for hyper-growth life sciences companies.
Money raised by biopharma: 2022 vs. 2021 vs. 2020 vs. 2019
Total raised in public, private and other financings of biopharma companies, comparing 2022 vs. 2021 vs. 2020 vs. 2019.
Oragenics Engages KBI Biopharma to Support Development of the Intranasal COVID-19 Vaccine Candidate NT-CoV2-1
KBI to produce material for use in upcoming Phase 2 clinical trial of Oragenics’ intranasal vaccine candidate.
Armed with heaps of cash and a veteran team, an upstart looks to disrupt DNA sequencing
Element Biosciences boasted that its sequencer, Aviti, has the right blend of affordability, accuracy, and flexibility to disrupt the current sequencing landscape.
Listen: Gilead’s growing pains, Covid’s origins, & Theranos as prestige TV
Dive into the 200th episode of "The Readout LOUD" #podcast: Can biotech companies age gracefully? Where did Covid-19 come from? And does Theranos make for good television? We cover all that ...
Lifebit and Boehringer Ingelheim Partner Up to Maximize the Value of Biobank Data for Innovative Medicines
Digitalization or computational biology can offer biobanks great opportunities to enhance their performance.
MorphoSys Eats $250M, Centralizes Operations in Germany
The drop in value has prompted MorphoSys to make drastic changes, such as discontinuing its U.S. operations and abandoning several pipeline projects.
For Sanofi Scientist Amy Richards, Research Is Personal
Amy Richards is a researcher at Sanofi’s lab in Framingham, Mass. focusing on rare neurodegenerative diseases.